浏览全部资源
扫码关注微信
遵义医学院附属医院肿瘤科 贵州省遵义市外环路,563003
纸质出版:1998
移动端阅览
[1]张逸群.肝夏乐配合介入疗法治疗晚期肝癌疗效分析[J].中医杂志,1998(10):601-602+580.
Ganfule Concerted with Interventional Therapy for Late Stage of Liver Carcinoma[J]. Journal of Traditional Chinese Medicine1998, (10): 601-602.
[1]张逸群.肝夏乐配合介入疗法治疗晚期肝癌疗效分析[J].中医杂志,1998(10):601-602+580. DOI: 10.13288/j.11-2166/r.1998.10.018.
Ganfule Concerted with Interventional Therapy for Late Stage of Liver Carcinoma[J]. Journal of Traditional Chinese Medicine1998, (10): 601-602. DOI: 10.13288/j.11-2166/r.1998.10.018.
1996年3月~1997年3月间
经影像学检查和AFP检测确诊的9例原发性巨块形晚期肝癌患者
均于动脉导管内介入治疗前后服用肝复乐
其中6例(67%)行单纯灌注化疗
其余3例行化疗栓塞术。从临床症状的改善
肝功能恢复
AFP降低以及生存期的长短等方面来看
肝复乐配合介入治疗
能有效地改善因肝硬化或肝癌引起的临床症状和肝功能异常
降低AFP
对改善晚期肝癌患者的生存质量
延长生存期起了一定的作用。
Nine cases of large cancer of liver in its late stage
being diagnosed by image examination and AFP test
during the period of March 1996 - March 1997 were treated interventionally with arterial catheter
concerted with oral Ganfule before and after the operation. Of them
6 cases (67%) received simple perfusion of chemotherapy
the other 3 received chemotherapeutic embolus formation. Judging from clinical symptoms
improvement of hepatic functions
lowering of AFP and survival time
this concerted therapy can effectively ameliorate the symptoms and abnormal hepatic functions due to the cancer or liver cirrhosis
lower AFP
thus improving the survival quality and prolonging the survival time for the patients.
0
浏览量
54
下载量
CSCD
关联资源
相关文章
相关作者
相关机构